PL
PL · PL · PL-100366360
Xanderla
ATC L02AE03
Last synced from URPL (Poland) on
Identification
ManufacturerTeva Pharmaceuticals Polska Sp. z o.o.
CountryPL (PL)
ATC codeL02AE03
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 3
- gtin05909991335564
- gtin05909991335571
- gtin05909991335588
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Implant w ampułko-strzykawce",
"source": "urpl",
"strength": "3,6 mg",
"packaging": "05909991335564 ¦ Rp ¦ 123208\n1 amp.-strzyk. 3,6 mg\n05909991335571 ¦ Rp ¦ 123209\n2 amp.-strzyk. 3,6 mg\n05909991335588 ¦ Rp ¦ 123210\n3 amp.-strzyk. 3,6 mg",
"substance": "Goserelini acetas 4,1 mg (w postacji Goserelinum 3,6 mg)",
"common_name": "Goserelinum",
"pl_product_id": "100366360",
"pozwolenie_nr": "24306",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}Related drugs
Other records sharing ATC code L02AE03.
- GBGoserelin 3.6mg implant pre-filled syringesA A H Pharmaceuticals Ltd
- GBNovgos 3.6mg implant pre-filled syringesGenus Pharmaceuticals Ltd
- PLReseligoZentiva, k.s.
- ISReseligoZentiva k.s.*
- ISReseligoAlvogen ehf.
- PLReseligoZentiva, k.s.
- CZRESELIGOAlvogen Pharma Trading Europe EOOD, Sofia
- CZRESELIGOAlvogen Pharma Trading Europe EOOD, Sofia
Access this data programmatically
Query Xanderla and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.